Sodium Chloride 0.9% Injection shortage
To Be Discontinued 3 presentations · 1 manufacturers · first FDA posting Dec 3, 2025 · last update Dec 3, 2025
Manufacturers: Hospira, Inc., a Pfizer Company
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Sodium Chloride 0.9%, Injection, 250 mL ADD-Vantage® Flexible Container (NDC 0409-7101-02) | Hospira, Inc., a Pfizer Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Dec 3, 2025 Updated Dec 3, 2025 Discontinued Dec 3, 2025 |
| Sodium Chloride 0.9%, Injection, 50 mL ADD-Vantage® Flexible Container (NDC 0409-7101-66) | Hospira, Inc., a Pfizer Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Dec 3, 2025 Updated Dec 3, 2025 Discontinued Dec 3, 2025 |
| Sodium Chloride 0.9%, Injection, 100 mL ADD-Vantage® Flexible Container (NDC 0409-7101-67) | Hospira, Inc., a Pfizer Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Dec 3, 2025 Updated Dec 3, 2025 Discontinued Dec 3, 2025 |